Conversion of normal human oral keratinocytes to tumorigenic cells is associated with the acquisition of resistance to TGF-ß

International Journal of Oncology

Volumn 12, Issue 4, 1998, Pages 833-839

  Woo, Kyung Mi ^a,b   Lee, Gene ^a   Kook, Joong Ki ^a   Min, Byung Moo ^a  

^a Seoul National University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

Author keywords

Apoptosis; Cell proliferation; Oral keratinocytes; TGF ; TGF receptor

Indexed keywords

DNA FRAGMENT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WART VIRUS;

APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; KERATINOCYTES; MOUTH MUCOSA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031916811     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kimchi A, Wang X-F, Weinberg RA, Cheifetz S and Massague J: Absence of TGF-ß receptors and growth inhibitory responses in retinoblastoma cells. Science 244: 196-199, 1988.
2. Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S and Yuspa SH: Loss of expression of transforming growth factor ß in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 90: 6076-6080, 1993.
3. Vojta PJ and Barrett JC: Genetic analysis of cellular senescence. Biochim Biophys Acta 1242: 29-41, 1995.
4. Raff MC: Social controls on cell survival and cell death. Nature 356: 397-400, 1992.
5. Jacobson MD, Burne JF and Raff MC: Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13: 1899-1910, 1994.
6. Kerr JFR, Wyllie AH and Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
7. Vaux DL, Haecker G and Strasser A: An evolutionary perspective on apoptosis. Cell 76: 777-779, 1994.
8. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
9. Hoffman B and Libermann DA: Molecular controls of apoptosis: differentiation/growth arrest primary response genes, protooncogenes and tumor suppressor genes as positive and negative modulators. Oncogene 9: 1807-1812, 1994.
10. Roberts AB and Sporn MB: The transforming growth factor-ßs, In: Peptide Growth Factors and their Receptors I: Handbook of experimental pharmacology. Vol. 95/I. Roberts AB and Sporn MB (eds.) Springer-Verlag, Berlin, Heidelberg, pp419-472, 1990.
11. Chen R-H, Ebner R and Derynck R: Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-ß activities. Science 260: 1335-1338, 1993.
12. Wrana JL, Attisano L, Wieser R, Ventura F and Massague J: Mechanism of activation of the TGF-ß receptor. Nature 370: 341-347, 1994.
13. Shipley GD, Pittelkow MR, Wille JJ Jr, Scott RE and Moses HL: Reversible inhibition of normal human prokeratinocyte proliferation by type ß transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 46: 2086-2071, 1986.
14. Attisano L, Wrana JL, Lopez-Casillas F and Massague J: TGF-ß receptors and actions. Biochim Biophys Acta 1222: 71-80, 1994.
15. 1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci USA 91: 11576-11580, 1994.
16. Yingling JM, Wang X-F and Bassing CH: Signaling by the transforming growth factor-ß receptors. Biochem Biophys Acta 1242:115-136, 1995.
17. 1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 88: 3412-3415, 1991.
18. 1 as a signal for induction of cell death by apoptosis. Br J Cancer 67: 531-536, 1993.
19. 1. Proc Natl Acad Sci USA 89: 5408-5412, 1992.
20. Min B-M, Woo KM, Back J-H, Lee G and Park N-H: Malignant transformation of HPV-immortalized human oral keratinocytes by chemical carcinogens. Int J Oncol 7: 249-256, 1995.
21. Park N-H, Min B-M, Li S-L, Huang M-Z, Cherrick HM and Doniger J: Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12: 1627-1631, 1991.
22. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
23. Partridge M, Green MR, Langdon JD and Feldmann M: Production of TGF-α and TGF-ß by cultured keratinocytes, skin and oral squamous cell carcinomas-potential autocrinc regulation of normal and malignant epithelial cell proliferation. Br J Cancer 60:542-548, 1989.
24. 2. Ann NY Acad Sci 593: 303-305, 1990.
25. Coffey RJ Jr, Sipes NJ, Bascom CC, Graves-Deal R, Pennington CY, Weissman BE and Moses HL: Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res 48: 1596-1602, 1988.
26. Lyons RM and Moses HL: Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 187: 467-473, 1989.
27. 1 on proliferation and death of rat prostatic cells. Endocrinology 127: 2963-2968, 1990.
28. Oberhammer F, Bursch W, Parzefall W, Breit P, Eber E, Stadler M and Schulte-Hermann R: Effect of transforming growth factor-ß on cell death of cultured rat hepatocytes. Cancer Res 51: 2478-2485, 1991.
29. INK4B is a potential effector of TGF-ß-induced cell cycle arrest. Nature 371: 257-261, 1994.
30. Taya Y: Cell cycle-dependent phosphorylation of the tumor suppressor RB protein. Mol Cells 5: 191-195, 1995.
31. 1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 52: 4042-4045, 1992.
32. 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev 8: 2429-2440, 1994.
33. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB and Sporn MB: Genetic changes in the transforming growth factor ß (TGF-ß) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-ß. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
34. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV: Inactivation of the type II TGF-ß receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
35. Sporn MB and Roberts AB: Autocrine growth factors and cancer. Nature 313: 745-747, 1985.
36. Roberts AB, Thompson NL, Heine U, Flanders C and Sporn MB: Transforming growth factor ß: Possible roles in carcinogenesis. Br J Cancer 57: 594-600, 1988.